Combination treatment with an erythropoiesis-stimulating agent and intravenous iron alleviates anaemia in patients with hereditary haemorrhagic telangiectasia

BACKGROUND: Patients with hereditary haemorrhagic telangiectasia (HHT) suffer from recurrent epistaxis and bleeding from gastrointestinal telangiectasias that occur despite otherwise normal haemostasis and result in iron deficiency anaemia with increasing severity. In advanced disease, anaemia may b...

Descripción completa

Detalles Bibliográficos
Autores principales: Cherif, Honar, Karlsson, Torbjörn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Informa Healthcare 2014
Materias:
Case Report From Uppsala University Hospital
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4248076/
https://www.ncbi.nlm.nih.gov/pubmed/25188751
http://dx.doi.org/10.3109/03009734.2014.955619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4248076/
https://www.ncbi.nlm.nih.gov/pubmed/25188751
http://dx.doi.org/10.3109/03009734.2014.955619

Ejemplares similares